News summary

Associations between a series of composite glucose-lipid indices and moderately increased albuminuria in patients with type 2 diabetes mellitus: a cross-sectional study

Source: Frontiers - Health • Published: 08 Oct 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

This article previews a cross-sectional study examining how several combined glucose–lipid indices relate to early kidney damage markers in adults with type 2 diabetes. It invites clinicians and researchers curious about metabolic markers that might help flag moderately increased albuminuria.

Associations between a series of composite glucose-lipid indices and moderately increased albuminuria in patients with type 2 diabetes mellitus: a cross-sectional study
Key Takeaways
  • Higher TyG index values were associated with increased odds of moderately increased albuminuria in patients with T2DM.
  • Derived indices including TyG/HDL-c, TyG-AIP, CHG, and TyH-i also showed positive associations with albuminuria severity.
  • The study analyzed adult T2DM inpatients from March 2020 to February 2023 after excluding non-type 2 diabetes and advanced renal disease.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.